Ceftaroline activity against pathogens associated with complicated skin and skin structure infections: results from an international surveillance study.
about
Focus on JNJ-Q2, a novel fluoroquinolone, for the management of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infectionsPBP2a mutations causing high-level Ceftaroline resistance in clinical methicillin-resistant Staphylococcus aureus isolates.Clinical importance and epidemiology of quinolone resistance.Missense mutations in PBP2A Affecting ceftaroline susceptibility detected in epidemic hospital-acquired methicillin-resistant Staphylococcus aureus clonotypes ST228 and ST247 in Western Switzerland archived since 1998Efficacy of human simulated exposures of ceftaroline administered at 600 milligrams every 12 hours against phenotypically diverse Staphylococcus aureus isolatesActivity of ceftaroline and epidemiologic trends in Staphylococcus aureus isolates collected from 43 medical centers in the United States in 2009.Efficacy of a new fluoroquinolone, JNJ-Q2, in murine models of Staphylococcus aureus and Streptococcus pneumoniae skin, respiratory, and systemic infections.Randomized, double-blind, phase II, multicenter study evaluating the safety/tolerability and efficacy of JNJ-Q2, a novel fluoroquinolone, compared with linezolid for treatment of acute bacterial skin and skin structure infectionCutaneous infections and infestations: new therapiesCeftaroline in complicated skin and skin-structure infections.In vitro activity of ceftaroline against bacterial pathogens isolated from skin and soft tissue infections in Europe, Russia and Turkey in 2012: results from the Assessing Worldwide Antimicrobial Resistance Evaluation (AWARE) surveillance programme.Whole-Genome Sequencing of Methicillin-Resistant Staphylococcus aureus Resistant to Fifth-Generation Cephalosporins Reveals Potential Non-mecA Mechanisms of Resistance.Efficacy of human simulated exposures of ceftaroline against phenotypically diverse Enterobacteriaceae isolatesReduced In Vitro Activity of Ceftaroline by Etest among Clonal Complex 239 Methicillin-Resistant Staphylococcus aureus Clinical Strains from AustraliaGlobal fluoroquinolone resistance epidemiology and implictions for clinical use.Efficacy of ceftaroline fosamil in a staphylococcal murine pneumonia model.Pharmacodynamics of Ceftolozane plus Tazobactam Studied in an In Vitro Pharmacokinetic Model of InfectionSingle- and multiple-dose study to determine the safety, tolerability, and pharmacokinetics of ceftaroline fosamil in combination with avibactam in healthy subjectsPenetration of Ceftaroline into the Epithelial Lining Fluid of Healthy Adult Subjects.Resistance surveillance studies: a multifaceted problem--the fluoroquinolone example.Critical appraisal of ceftaroline in the management of community-acquired bacterial pneumonia and skin infections.Ceftaroline fosamil: a new cephalosporin active against resistant Gram-positive organisms including MRSA.Ceftaroline fosamil: a review of its use in the treatment of complicated skin and soft tissue infections and community-acquired pneumonia.Penicillin-binding protein 2a of methicillin-resistant Staphylococcus aureus.Skin and soft-tissue infections: a critical review and the role of telavancin in their treatment.Susceptibility testing challenges with ceftaroline, MRSA and a 1 mg/L breakpoint.Use of Ceftaroline Fosamil in Children: Review of Current Knowledge and its Application.Pharmacokinetic-pharmacodynamic target attainment analyses to evaluate in vitro susceptibility test interpretive criteria for ceftaroline against Staphylococcus aureus and Streptococcus pneumoniae.Pharmacodynamics of ceftaroline against Staphylococcus aureus studied in an in vitro pharmacokinetic model of infection.Characterization of methicillin-resistant Staphylococcus aureus displaying increased MICs of ceftaroline.Ceftaroline Resistance by Clone-Specific Polymorphism in Penicillin-Binding Protein 2a of Methicillin-Resistant Staphylococcus aureus
P2860
Q26746197-5347DC95-7AE9-4DF0-837A-F7C973EFDEF1Q34596507-0032DDA6-D4A8-42C0-AFD2-C56CEB83E7DDQ34838791-D93FCF6A-CCDF-4A46-ACDB-087E310FAA3BQ35169054-7540EB8D-78EE-450B-8A9D-1628FC56EC1EQ35191501-0D840763-2B65-4E28-A011-B6D9A49269E2Q35191527-322A94C6-E80C-4EAC-8D97-3AC221F71DD2Q35598346-D5E84F47-BC5A-4685-82F4-018ACC0542C9Q35598552-4E750A6C-C0D2-47A9-98DD-CB3745D32A0FQ35628618-78A13CCA-21CE-41CD-9E4F-F5D2BF9D01B8Q35715381-723AD09E-6F60-46E1-A9D9-9D52515A5B6DQ35822261-0C547542-81F6-44CD-BDA3-72DC8BE1F70CQ35927293-47186C72-2CEF-4FE9-ABEB-6594EDEA20A6Q35941308-3A309FC9-9741-4069-9DD8-A3634F104110Q36290502-69FDA6F3-0FD3-4D1B-A10D-E1F546498D01Q36337074-366AEF99-76D7-4C92-9260-AFEF318DA662Q36396172-6C41B861-A8C5-4BD8-BC94-3C7D8A76BE7AQ36438924-50658395-9B39-41E5-8A49-BC5C4B931BF8Q36667104-150A43FA-E5DC-47E4-9F74-B19CFD6BAC3DQ37287884-64A471AF-ED74-4910-AB0A-85DB39E28EBEQ37998398-84FA8E04-E7FA-4BDC-801B-6EB17C1FC60CQ38006689-86425A7A-E66C-4C8D-AF16-6EA0B4263868Q38061168-18F3CB84-C8A4-46A8-B1FC-3FD2C4915B9BQ38117077-16B7CB3F-C4A4-46DD-9D01-BA67C5F098DBQ38232037-B8CFB503-76E9-4092-9125-3C64360C6EF6Q38575717-60F08B75-C70B-4199-B062-792AE81569CEQ38575948-B8BED326-02CC-4FAB-BD93-AD235984097BQ39048083-A5BA0B73-98E9-43C0-BE49-2F9863D31F05Q41907687-6980274C-7CEF-4886-9F82-6E97A3740490Q42275442-8708B59D-84CA-4478-B598-082236FEBCCDQ44814819-F200C2DF-DFC1-4B5E-933C-E95C328A26D4Q57210839-F24D5222-EBE0-46F1-A66C-7E49AAC0DD63
P2860
Ceftaroline activity against pathogens associated with complicated skin and skin structure infections: results from an international surveillance study.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Ceftaroline activity against p ...... ernational surveillance study.
@en
Ceftaroline activity against p ...... ernational surveillance study.
@nl
type
label
Ceftaroline activity against p ...... ernational surveillance study.
@en
Ceftaroline activity against p ...... ernational surveillance study.
@nl
prefLabel
Ceftaroline activity against p ...... ernational surveillance study.
@en
Ceftaroline activity against p ...... ernational surveillance study.
@nl
P356
P1476
Ceftaroline activity against p ...... ernational surveillance study.
@en
P2093
Rodrigo E Mendes
Ronald N Jones
P304
P356
10.1093/JAC/DKQ252
P407
P478
65 Suppl 4
P577
2010-11-01T00:00:00Z